Post job

Yield10 Bioscience's revenue is $60,000.

What is Yield10 Bioscience's revenue?

Yield10 Bioscience's annual revenue is $60.0K. Zippia's data science team found the following key financial metrics about Yield10 Bioscience after extensive research and analysis.
  • Yield10 Bioscience's revenue growth from 2005 to 2023 is -97.84%.
  • Yield10 Bioscience has 25 employees, and the revenue per employee ratio is $2,400.
  • Yield10 Bioscience's peak quarterly revenue was $39.3M in 2012(q1).
  • Yield10 Bioscience peak revenue was $41.4M in 2012.
  • Yield10 Bioscience annual revenue for 2022 was 450.0K, -26.71% growth from 2021.
  • Yield10 Bioscience annual revenue for 2023 was 60.0K, -86.67% growth from 2022.

On this page

Most recent quarter revenue
$450,000 (Q2'2024)
Company most recent quarter revenue
Peak revenue
$41.4M (2012)
Company peak revenue
Revenue / employee
$2,400
Company revenue / employee

Zippia finds jobs where you're a top candidate and applies on your behalf.

Floating question marks illustration
Most recent quarter revenue
$450,000 (Q2'2024)
Company most recent quarter revenue
Peak revenue
$41.4M (2012)
Company peak revenue
Revenue / employee
$2,400
Company revenue / employee

Yield10 Bioscience historical revenue

Yield10 Bioscience's peak revenue was $41.4M in 2012. The peak quarterly revenue was $39.3M in 2012(q1).

Yield10 Bioscience's revenue increased from $2.8m in 2005 to $60.0K currently. That's a -97.84% change in annual revenue.

Yield10 Bioscience annual revenue

$41M
$33M
$25M
$17M
$8M
$0
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023

Yield10 Bioscience annual revenue over time

Fiscal year / yearYield10 Bioscience revenue
2009$1.4M
2010$448,000
2011$1.4M
2012$41.4M
2013$3.8M
2014$2.8M
2015$1.4M
2016$1.2M
2017$944,000
2018$556,000
2019$806,000
2020$799,000
2021$614,000
2022$450,000
2023$60,000

How accurately did Yield10 Bioscience's revenue projections match actual performance?

Zippia waving zebra

Yield10 Bioscience annual growth

Yield10 Bioscience saw the greatest revenue growth in 2012, when revenue increased by 2,803.93%.

Yield10 Bioscience had the lowest revenue growth in 2013, when revenue changed by -90.87%.

Yield10 Bioscience annual growth rate over time

YearYield10 Bioscience growth
2009
-8%
2010
-69%
2011
218%
2012
2804%
2013
-91%
2014
-26%
2015
-52%
2016
-14%
2017
-19%
2018
-41%
2019
45%
2020
-1%
2021
-23%
2022
-27%
2023
-87%

Yield10 Bioscience quarterly revenue over time

  • Q1
  • Q2
  • Q3
  • Q4
$450,000
$360,000
$270,000
$180,000
$90,000
$0
2020
2021
2022
2023
2024

Yield10 Bioscience quarterly growth rate over time

YearQ1Q2Q3Q4
2009$261,000$348,000$611,000$205,000
2010$180,000$109,000$46,000$113,000
2011$326,000$191,000$469,000$439,000
2012$39.3M$923,000$674,000$462,000
2013$1.9M$1.7M$629,000$30,000
2014$613,000$699,000$632,000$856,000
2015$645,000$744,000$327,000$101,000
2016$157,000$188,000$473,000$341,000
2017$324,000$293,000$223,000$104,000
2018$60,000$285,000$76,000$135,000
2019$124,000$318,000$224,000$140,000
2020$179,000$221,000$204,000$195,000
2021$196,000$174,000$92,000$152,000
2022$149,000$103,000$111,000$87,000
2023$60,000---
2024$300,000$450,000--

Yield10 Bioscience jobs nearby

Do you work at Yield10 Bioscience?

Did Yield10 Bioscience meet its revenue projections?

Yield10 Bioscience financial information

IndustryPharmaceuticals, Biotechnology & Life Sciences
Company TypePublic
Employees Number25
Date Founded1992
HeadquartersWoburn, Massachusetts
Number of Locations1
Revenue$60,000
Net Income-$13,566,000
Gross Proft$1.3M (2014)
PE Ratio-0.75
Tax Rate-0.0%
Market Capitalization$10.8M
Total Assets$8,085,000
TickerYTEN

Yield10 Bioscience jobs you might like

Yield10 Bioscience financing

Yield10 Bioscience received early financing of $10.8M on 2000-01-01.

SeriesRound sizeDate
Series Unknown$10.8M01/2000
Grant$6M05/2011
Private Equity$51.7M05/2011
Post Ipo Equity$25M08/2014
Post Ipo Equity$11.5M11/2019
Post Ipo Equity$4M08/2020
Post Ipo Equity$12.7M01/2021

Yield10 Bioscience investors

InvestorsSecurity type
United States Department of Agriculture (USDA)Grant
Department of EnergyGrant
Jack SchulerPost Ipo Equity
Oracle Investment ManagementPost Ipo Equity
Jack SchulerPost Ipo Equity
Jack W. Schuler Living TrustPost Ipo Equity

Yield10 Bioscience competitors

Yield10 Bioscience's top competitor, Johnson & Johnson, earned an annual revenue of $88.8B.

Yield10 Bioscience's smallest competitor is Medivation with revenue of $1.0B last year.

Yield10 Bioscience revenue FAQs

Search for jobs

Zippia gives an in-depth look into the details of Yield10 Bioscience, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Yield10 Bioscience. The employee data is based on information from people who have self-reported their past or current employments at Yield10 Bioscience. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Yield10 Bioscience. The data presented on this page does not represent the view of Yield10 Bioscience and its employees or that of Zippia.

Yield10 Bioscience may also be known as or be related to YIELD10 BIOSCIENCE INC., YIELD10 BIOSCIENCE, INC., Yield10 Bioscience, Yield10 Bioscience Inc, Yield10 Bioscience, Inc. and Yield10 Bioscience, Inc.,.